KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Fulgent Genetics (FLGT) Long-Term Deferred Tax (2016 - 2019)

Fulgent Genetics (FLGT) has disclosed Long-Term Deferred Tax for 4 consecutive years, with $1.1 million as the latest value for Q4 2019.

  • Quarterly Long-Term Deferred Tax changed N/A to $1.1 million in Q4 2019 from the year-ago period, while the trailing twelve-month figure was $1.1 million through Dec 2019, changed N/A year-over-year, with the annual reading at $1.1 million for FY2019, N/A changed from the prior year.
  • Long-Term Deferred Tax hit $1.1 million in Q4 2019 for Fulgent Genetics, up from $929000.0 in the prior quarter.
  • In the past five years, Long-Term Deferred Tax ranged from a high of $1.1 million in Q4 2019 to a low of $27000.0 in Q3 2017.
  • Historically, Long-Term Deferred Tax has averaged $348200.0 across 4 years, with a median of $106000.0 in 2016.
  • Biggest five-year swings in Long-Term Deferred Tax: crashed 68.6% in 2017 and later surged 3340.74% in 2018.
  • Year by year, Long-Term Deferred Tax stood at $54000.0 in 2016, then soared by 133.33% to $126000.0 in 2017, then soared by 637.3% to $929000.0 in 2018, then increased by 16.47% to $1.1 million in 2019.
  • Business Quant data shows Long-Term Deferred Tax for FLGT at $1.1 million in Q4 2019, $929000.0 in Q3 2018, and $592000.0 in Q2 2018.